Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410466 | SCV000489427 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2016-10-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000439045 | SCV000512516 | benign | not specified | 2015-04-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000579900 | SCV000684323 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000410466 | SCV002464399 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2024-01-30 | criteria provided, single submitter | clinical testing | |
European Reference Network on Genetic Tumour Risk Syndromes |
RCV000410466 | SCV003926719 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2022-08-01 | criteria provided, single submitter | clinical testing | PM2 (PMID: 30311375) |
Myriad Genetics, |
RCV000410466 | SCV004019546 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2023-03-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |